IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndromes; Leukemia Acute Myeloid Intervention: Drug: AG-221 Sponsor: Groupe Francophone des Myelodysplasies Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Myelodysplastic Syndrome | Research